Category: Neurological

Neurological

5 Lessons Learned from CHLA’s Pediatric Gait Lab

Analysis at the CHLA pediatric gait lab plays a critical role in determining the most effective treatments for children with walking issues.

Neurological

Is Smoking Tied to Cryptogenic Stroke in Younger Adults?

For the study, researchers looked at 546 people ages 18 to 49 who had an unexplained stroke and asked about their habits, including smoking.

Neurological

Keys to Effective Therapy for Neurological Damage

In this Physical Therapy Products feature, Deborah Struiksma, PT, NCS, shares how consistent physical therapy with tried-and-true techniques helps patients with neurological damage restore compromised functions.

Brain Injury

NIH Funding Research to Investigate TBI-Dementia Link

An international team of researchers led by Penn Medicine will investigate the link between TBI and dementias over the next five years.

Functional Electrical Stimulation

Study: Product Improves Gait in Patients with Foot Drop, MS

The real-world study evaluated the impact of this approach to address neuromuscular walking challenges associated with foot drop.

Gait & Balance

OneStep Secures Funding for Gait Analysis Tool

OneStep has secured $36 million to expand its smartphone-based gait analysis technology, aiming to make gait a widely-recognized "sixth vital sign" for health monitoring and disease management.

Multiple Sclerosis

These MS Therapies May Not Slow Disability Progression

In people with primary progressive MS, a new study compared time before disability worsened between people receiving certain MS therapies and those not receiving treatment.

Strokes

Study: Black Stroke Patients Arrive Later to Hospitals

Black stroke patients arrive later to emergency departments, and EMS is less likely to notify hospitals of their condition ahead of time, a national study shows.

Parkinson’s Disease

Dosing Begins in Solengepras Parkinson’s Therapy Phase 3 Trial

Cerevance has initiated the Phase 3 ARISE trial to evaluate solengepras, a non-dopaminergic therapy targeting specific brain circuits, as a potential adjunctive treatment for Parkinson's disease.